m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

m6A-modified RIPK4 facilitates proliferation and cisplatin resistance in epithelial ovarian cancer

Published:2024-01 Issue: Volume:180 Page:99-110
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Yin Xinming,Zhao Shijie,Zhang Mengxue,Xing Jie,Zhou Jiamin,Gao Wujiang,Chen Lu,Zhang Yajiao,Lin Li,Lu Minjun,Li Wenxin,Shang Junyu,Zhu Xiaolan

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference47 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

2. Hopes and failures in front-line ovarian cancer therapy;Tsibulak;Crit. Rev. Oncol. Hematol.,2019

3. “Platinum resistant” ovarian cancer: what is it, who to treat and how to measure benefit?;Davis;Gynecol. Oncol.,2014

4. FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation;Zhou;Mol. Carcinog.,2018

5. m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistance;Zhou;Signal Transduct. Target. Ther.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets;Clinical and Translational Medicine;2024-08

2. Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects;Frontiers in Oncology;2024-03-13

3. Methyltransferase‐like 3 mediated RNA m⁶A modifications in the reproductive system: Potentials for diagnosis and therapy;Journal of Cellular and Molecular Medicine;2024-02

4. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer;Cancer Control;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3